Diagnostic methods and kit for determining kell blood group geno

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 12, 435 71, 43524027, 4352521, 435 691, 424 22, 530300, 5303881, 536 231, 536 243, 536 2433, C12Q 168, C12P 1934, C07H 2102, C07K 500

Patent

active

058043799

ABSTRACT:
The invention provides a diagnostic method of determining Kell genotype by the identification of the molecular basis of a Kell polymorphism. Specifically, the invention provides a method for determining K1/K2 genotype with great accuracy, overcoming problems associated with traditional serological typing methods. The diagnostic method of the invention preferably employs amplification of K1/K2 nucleic acid sequences, and optionally employs differential cleavage of K1- and K2-specific nucleic acid sequences by a restriction enzyme. Also provided are nucleic acid oligomers useful as probes or primers for the method of the invention. Furthermore, diagnostic kits for the determination of Kell genotype are provided.

REFERENCES:
patent: 4148607 (1979-04-01), Bernoco et al.
patent: 4358436 (1982-11-01), Graham, Jr. et al.
patent: 4403042 (1983-09-01), Henry et al.
patent: 4560647 (1985-12-01), Stocker
patent: 5213963 (1993-05-01), Uthemann
patent: 5302512 (1994-04-01), Pernelle
patent: 5324479 (1994-06-01), Naldoni et al.
patent: 5589336 (1996-12-01), Lee et al.
Berkowitz et al., "Death in utero due to Kell sensitization without excessive elevation of the .increment.od.sub.450 value in amniotic fluid," Obstetrics & Gynecology, 60(6): 746-749 (1982).
Branch et al., "Disulfide bonds are a requirement of Kell and Cartwright (Yt.sup.a) blood group antigen integrity," Br. J. Haematol. 54: 573-78 (1993).
Bowman et al., "Maternal Kell blood group alloimmunization," Obstetrics & Gynecology, 79(2): 239-244 (1992).
Chang et al., "Molecular characterization of erythrocyte glycophorin c variants," The American Society of Hematology--Blood, 77(3): 644-648 (1991).
Cherif-Zahar et al., "Organization of the gene (RHCE) encoding the human blood group RhCcEe antigens and characterization of the promoter region," Genomics 19: 68 (1994).
Constantine, "Anti-Kell in pregnancy," Lancet, 338: 198 (1991).
Constantine et al., "Anti-Kell in pregnancy," British Journal of Obstetrics and Gynaecology, 98: 943-944 (1991).
Cullen, "Erythroblastosis fetalis produced by Kell immunization: Dental findings," Pediatric Dentistry, 12(6): 393-396 (1990).
Duguid et al., "Haemolytikc disease of the newborn due to anti-k," Vox Sang, 58: 69 (1990).
Furuhjelm et al., "The blood group antigen U1.sup.a (Karhula)," Vox Sang. 15: 118-24 (1968).
Giblett et al., "A critique of the theoretical hazard of inter- vs. intra-racial transfusion," Transfusion 1: 233 (1961).
Giblett et al., "Js.sup.a a `new` red cell antigen found in negroes: evidence for an eleventh blood group system," Brit J. Haematol. 5: 319-26 (1959).
Gusdon, Jr. et al., "Amniotic fluid analysis in erythroblastosis secondary to Kell immunization," Obstetrics and Gynecology, 33(3): 432-434 (1969).
Hardie et al., "Neuroacanthocytosis--a clinical, haematological and pathological study of 19 cases," Oxford University Press--Brain, 114: 13-44 (1991).
Jaber et al., "Characterization of murine monoclonal antibodies directed against the Kell blood group glycoprotein," British Journal of Haematology, 79: 311-315 (1991).
Jaber et al., "Characterization of the blood group Kell (k1) antigen with a human monoclonal antibody," Blood, 73(6): 1597-1602 (1989).
Lee et al., "The human Kell blood group gene maps to chromosome 7q33 and its expression is restricted to erythroid cells," The American Society of Hematology--Blood, 81(10): 2804-2809 (1993).
Lee et al., "Molecular cloning and primary structure of Kell blood group protein," Proc. Natl. Acad. Sci. USA, 88: 6353-6357 (1991).
Leggat et al., "Anti-Kell in pregnancy," British Journal of Obstetrics and Gynaecology, 98: 162-165 (1991).
Marsh et al., "Blood groups of human red cells in clinical practice of blood transfusion," (Petz et al. eds.) pp. 79-130, Churchill-Livingstone, New York (1981).
Marsh et al., "Recent developments in the Kell blood group system," Transfusion Medicine Reviews, 1(1): 4-20 (1987).
Marsh et al., "The Kell blood group system: a review," Transfusion, 30(2): 158-167 (1990).
Mayne et al., "The significance of anti-Kell sensitization in pregnancy," Clin. Lab. Haemat., 12: 379-385 (1990).
Moncharmont et al., "A case of hemolytic disease of the newborn infant due to anti-k (cellano)," Acta Haematol, 85: 45-46 (1991).
Murphy et al., "Regional chromosomal assignment of the Kell blood group locus (kel) to chromosome 7q33-q35 by fluorescence in situ hybridization: evidence for the polypeptide nature of antigenic variation," Human Genetics, 91: 585-588 (1993).
Parsons et al., "Monoclonal antibodies against Kell glycoprotein: serology, imunochemistry and quantification of antigen sites," Transfusion Medicine, 3: 1-6 (1993).
Petty et al., "Application of the maiea assay to the Kell blood group system," Vox Sang, 66: 216-224 (1994).
Purohit et al., "The Kell blood group locus is close to the cystic fibrosis locus on chromosome 7," Human Genetics, 89: 457-458 (1992).
Redman et al., "Kell blood group antigens are part of a 93,000-Dalton red cell membrane protein*," The Journal of Biological Chemistry, 261(20): 9521-9525 (1986).
Redman et al., "Comparison of human and chimpanzee Kell blood group systems," Transfusion, 29(6): 486-490 (1989).
Redman et al., "Isolation of Kell-active protein from the red cell membrane," Transfusion, 24(2): 176-178 (1984).
Redman et al., "The Kell antigens and McLeod red cells:" 53-69.
Redman et al., "The Kell blood group system and the McLeod phenotype," Seminars in Hematology, 30(3): 209-218 (1993).
Telen et al., "Erythrocyte webb-type glycophorin c variant lacks n-glycosylation due to an asparagine to serine substitution," American Journal of Hematology, 37: 51-52 (1991).
Vaughn et al., "Anti-Kell in pregnancy," Lancet, 338: 199 (1991).
Wallas et al., "Isolation of a Kell-reactive protein from red cell membrane," Transfusion, 26(2): 173-175 (1986).
Zelinski et al., "Genetic Linkage between the Kell blood group system and prolactin-inducible protein loci: Provisional assignment of kel to chromosome 7," Human Genetics, 55: 137-140 (1991).
Zelinski, "The use of dna restriction fragment length polymorphisms in conjunction with blood group serology," Transfusion, 31(8): 762-770 (1991) .

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Diagnostic methods and kit for determining kell blood group geno does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnostic methods and kit for determining kell blood group geno, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic methods and kit for determining kell blood group geno will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1280998

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.